VCM
ONC

Versant Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Versant Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Buy
7
+4
+133% +$1.18K ﹤0.01% 2560
2026
Q1 		$891 Buy
+3
New +$971 ﹤0.01% 2665
2023
Q4 		– Sell
-8
Closed -$1.44K – 2028
2023
Q3 		$1.44K Hold
8
– – ﹤0.01% 1417
2023
Q2 		$1.43K Hold
8
– – ﹤0.01% 1498
2023
Q1 		$1.72K Buy
+8
New +$1.92K ﹤0.01% 1307

Other funds holding ONC

AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
WAS
WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
CST
Charles Schwab Trust Henderson, Nevada $1.79B AUM 17.47% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
JGGDR
JGP Global Gestao de Recursos Rio De Janeiro, Brazil $45.3M AUM 42.75% 1-Year Est. Return

Versant Capital Management's ONC Position: Q2 2026 in Review

Versant Capital Management increased its BeOne Medicines Ltd (ONC) stake by 133% in Q2 2026, buying an estimated $1.18K and bringing the position to 7 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2560.

Versant Capital Management first reported a position in ONC in Q1 2023 and has held it in 5 quarters since. 39 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Versant Capital Management held 7 shares of BeOne Medicines Ltd worth $2K as of Q2 2026.
  • Versant Capital Management bought 4 BeOne Medicines Ltd shares in Q2 2026, an estimated $1.18K.
  • BeOne Medicines Ltd made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2560 holding.
  • Versant Capital Management first reported a position in BeOne Medicines Ltd in Q1 2023 and has held it in 5 quarters since.
  • 39 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.